Search

Quick Filters

Compliance Status
Clear

Clinical Trials Data

Showing 543136 of 543136 entries
View as:

A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02108548 Org: User:
Start: 04/30/14 End: 03/31/15 Due: 03/31/16

Comparison of Thrust Manipulation of Sacroiliac Joint and Pelvic Stabilization Exercises in Post Partum Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT06303401 Org: User:
Start: 09/27/23 End: 08/30/24 Due: 08/30/25

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00320710 Org: User:
Start: 02/28/06 End: 07/31/13 Due: 07/31/14

Acute Effects of a Non Excitatory Cardial Stimulation

Phase: N/A Priority: Normal
NCT ID: NCT01789112 Org: User:
Start: 07/31/12 End: 06/30/17 Due: 06/30/18

Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04944914 Org: User:
Start: 06/01/21 End: 06/01/26 Due: 06/01/27

Cannabidiol After Multi-Trauma for Pain and Opioid Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06448923 Org: User:
Start: 09/30/24 End: 09/30/26 Due: 09/30/27

Personalized, Transdiagnostic Approach to Preventative Mental Health

Phase: N/A Priority: Normal
NCT ID: NCT03946319 Org: User:
Start: 05/31/19 End: 08/31/19 Due: 08/31/20

Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004043 Org: User:
Start: 02/28/99 End: 03/31/03 Due: 03/31/04

Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT02348918 Org: User:
Start: 10/13/14 End: 06/13/17 Due: 06/13/18

Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD)

Phase: N/A Priority: Normal
NCT ID: NCT01640119 Org: User:
Start: 07/31/14 End: 12/31/17 Due: 12/31/18

This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT03448419 Org: User:
Start: 03/20/18 End: 10/07/19 Due: 10/07/20